- Home
- CPIX vs OTLK Comparison
CPIX vs OTLK Comparison
Compare CPIX & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- OTLK
- Stock Information
- Founded
- CPIX 1999
- OTLK 2010
- Country
- CPIX United States
- OTLK United States
- Employees
- CPIX N/A
- OTLK N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CPIX Health Care
- OTLK Health Care
- Exchange
- CPIX Nasdaq
- OTLK Nasdaq
- Market Cap
- CPIX 37.9M
- OTLK 33.6M
- IPO Year
- CPIX 2009
- OTLK 2016
- Fundamental
- Price
- CPIX $2.53
- OTLK $2.23
- Analyst Decision
- CPIX
- OTLK Strong Buy
- Analyst Count
- CPIX 0
- OTLK 6
- Target Price
- CPIX N/A
- OTLK $23.08
- AVG Volume (30 Days)
- CPIX 509.3K
- OTLK 1.2M
- Earning Date
- CPIX 03-04-2025
- OTLK 02-12-2025
- Dividend Yield
- CPIX N/A
- OTLK N/A
- EPS Growth
- CPIX N/A
- OTLK N/A
- EPS
- CPIX N/A
- OTLK N/A
- Revenue
- CPIX $36,785,442.00
- OTLK N/A
- Revenue This Year
- CPIX N/A
- OTLK N/A
- Revenue Next Year
- CPIX N/A
- OTLK $603.93
- P/E Ratio
- CPIX N/A
- OTLK N/A
- Revenue Growth
- CPIX N/A
- OTLK N/A
- 52 Week Low
- CPIX $1.04
- OTLK $0.87
- 52 Week High
- CPIX $3.93
- OTLK $12.85
- Technical
- Relative Strength Index (RSI)
- CPIX 59.45
- OTLK 48.26
- Support Level
- CPIX $2.21
- OTLK $2.08
- Resistance Level
- CPIX $3.93
- OTLK $2.31
- Average True Range (ATR)
- CPIX 0.33
- OTLK 0.28
- MACD
- CPIX -0.00
- OTLK 0.12
- Stochastic Oscillator
- CPIX 20.00
- OTLK 60.54
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.